Results 161 to 170 of about 71,892 (273)

Activity of Elvitegravir, a Once‐Daily Integrase Inhibitor, against Resistant HIV Type 1: Results of a Phase 2, Randomized, Controlled, Dose‐Ranging Clinical Trial [PDF]

, 2010
Andrew Zolopa, Daniel S Berger, Harry Lampiris, Lijie Zhong, Steven L. Chuck, Jeffrey Enejosa, Brian P. Kearney, Andrew Cheng   +7 more
openalex   +1 more source

Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors: An Updated Review

Clinical Pharmacokinetics, 2020
A. Podany, K. Scarsi, Michelle M. Pham, C. Fletcher   +3 more
semanticscholar   +1 more source

Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase

, 2007
John M. Murray, Sean Emery, Anthony D. Kelleher, Matthew Law, Joshua Chen, Daria J. Hazuda, Bach‐Yen Nguyen, Hedy Teppler, David A. Cooper   +8 more
openalex   +1 more source

Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961) [PDF]

, 2010
Joseph J. Eron, JM Livrozet, Philippe Morlat, Adriano Lazzarin, Christine Katlama, Trevor Hawkins, Tamio Fujiwara, Robert L. Cuffe, Cindy Vavro, Julio Montes Santiago, Mounir Ait‐Khaled, Sherene Min, JM Yeo   +12 more
openalex   +1 more source

The Terminal (Catalytic) Adenosine of the HIV LTR Controls the Kinetics of Binding and Dissociation of HIV Integrase Strand Transfer Inhibitors

, 2008
David R. Langley, Himadri Samanta, Zeyu Lin, Michael Walker, Mark Krystal, Ira B. Dicker   +5 more
openalex   +1 more source

Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patients [PDF]

, 2011
Isabelle Malet, Marc Wirden, Slim Fourati, Daniele Armenia, Bernard Masquelier, Lavinia Fabeni, Sophie Sayon, Christine Katlama, Carlo Federico Perno, Vincent Cálvez, Anne‐Geneviève Marcelin, Francesca Ceccherini‐Silberstein   +11 more
openalex   +1 more source

Structural Biology of HIV Integrase Strand Transfer Inhibitors.

TIPS - Trends in Pharmacological Sciences, 2020
I. Jóźwik, D. Passos, D. Lyumkis
semanticscholar   +1 more source

Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors [PDF]

, 2011
Horrick Sharma, Shivaputra A. Patil, Tino W. Sanchez, Nouri Neamati, Raymond F. Schinazi, John K. Buolamwini   +5 more
openalex   +1 more source

HIV-1 integrase inhibitor T30177 forms a stacked dimeric G-quadruplex structure containing bulges [PDF]

, 2011
Vineeth Thachappilly Mukundan, Ngoc Quang, Anh Tuân Phan   +2 more
openalex   +1 more source

The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance [PDF]

, 2012
Mark A. Wainberg
openalex   +1 more source